INTEGRATED BIOPHARMA INC: 10-Q filed 2012-02-21

Name: INTEGRATED BIOPHARMA INC: 10-Q filed 2012-02-21
Creator: INTEGRATED BIOPHARMA INC

What INTEGRATED BIOPHARMA INC reported in its quarterly report filed 2012-02-21 (fiscal Q2 2012): 30 published measures, 82 facts as tagged in accession 0001016504-12-000011.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-02-21
Fiscal period: fiscal Q2 2012
Accession: 0001016504-12-000011 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INTEGRATED BIOPHARMA INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-12-31	11,530,000	USD
At 2011-06-30	13,650,000	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-12-31	-8,099,000	USD
At 2011-06-30	-7,695,000	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-12-31	388,000	USD
At 2011-06-30	563,000	USD
At 2010-12-31	347,000	USD
At 2010-06-30	478,000	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-784,000	USD	92
2011-07-01 to 2011-12-31	-422,000	USD	184
2010-10-01 to 2010-12-31	-423,000	USD	92
2010-07-01 to 2010-12-31	-424,000	USD	184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	-256,000	USD	184
2010-07-01 to 2010-12-31	1,145,000	USD	184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	7,000	USD	184
2010-07-01 to 2010-12-31	218,000	USD	184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	-20,000	USD	184
2010-07-01 to 2010-12-31	-22,000	USD	184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	-2,000	USD	184
2010-07-01 to 2010-12-31	-188,000	USD	184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-12-31	-52,603,000	USD
At 2011-06-30	-52,181,000	USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	20,986,813	shares	92
2011-07-01 to 2011-12-31	20,975,944	shares	184
2010-10-01 to 2010-12-31	20,797,139	shares	92
2010-07-01 to 2010-12-31	20,686,520	shares	184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-0.04	USD/shares	92
2011-07-01 to 2011-12-31	-0.02	USD/shares	184
2010-10-01 to 2010-12-31	-0.02	USD/shares	92
2010-07-01 to 2010-12-31	-0.02	USD/shares	184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-12-31	1,445,000	USD
At 2011-06-30	1,598,000	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	11,000	USD	184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	507,000	USD	92
2011-07-01 to 2011-12-31	1,247,000	USD	184
2010-10-01 to 2010-12-31	-120,000	USD	92
2010-07-01 to 2010-12-31	-72,000	USD	184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-12-31	9,903,000	USD
At 2011-06-30	11,853,000	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	172,000	USD	92
2011-07-01 to 2011-12-31	331,000	USD	184
2010-10-01 to 2010-12-31	515,000	USD	92
2010-07-01 to 2010-12-31	1,001,000	USD	184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-12-31	19,629,000	USD
At 2011-06-30	21,345,000	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-12-31	3,366,000	USD
At 2011-06-30	5,152,000	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2011-12-31	1,330,000	USD
At 2011-06-30	1,205,000	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2011-12-31	3,824,000	USD
At 2011-06-30	5,367,000	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	1,249,000	USD	92
2011-07-01 to 2011-12-31	2,678,000	USD	184
2010-10-01 to 2010-12-31	806,000	USD	92
2010-07-01 to 2010-12-31	1,764,000	USD	184

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	742,000	USD	92
2011-07-01 to 2011-12-31	1,431,000	USD	184
2010-10-01 to 2010-12-31	926,000	USD	92
2010-07-01 to 2010-12-31	1,836,000	USD	184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-12-31	20,980,174	shares
At 2011-06-30	20,880,174	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-12-31	44,561,000	USD
At 2011-06-30	44,543,000	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-657,000	USD	92
2011-07-01 to 2011-12-31	-63,000	USD	184
2010-10-01 to 2010-12-31	-635,000	USD	92
2010-07-01 to 2010-12-31	-1,035,000	USD	184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-992,000	USD	92
2011-07-01 to 2011-12-31	-979,000	USD	184
2010-07-01 to 2010-12-31	38,000	USD	184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-1,164,000	USD	92
2011-07-01 to 2011-12-31	-1,310,000	USD	184
2010-10-01 to 2010-12-31	-515,000	USD	92
2010-07-01 to 2010-12-31	-963,000	USD	184

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-26,000	USD	92
2011-07-01 to 2011-12-31	-26,000	USD	184
2010-10-01 to 2010-12-31	-5,000	USD	92
2010-07-01 to 2010-12-31	-12,000	USD	184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	-1,543,000	USD	184
2010-07-01 to 2010-12-31	-805,000	USD	184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2011-12-31	-1,786,000	USD	184
2010-07-01 to 2010-12-31	-1,737,000	USD	184

Inspect the source

Entity: INTEGRATED BIOPHARMA INC / CIK 0001016504
Captured: 2026-09-20T05:13:02.120Z
SEC response SHA-256: f9ec590a908b38ef1a59595c204a1a8d2ad866020a5c8107d7a41fc708faf496

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001016504.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))